Related Articles
Dihydroartemisinin-induced apoptosis in human acute monocytic leukemia cells
Dihydroartemisinin inhibits tumor growth of human osteosarcoma cells by suppressing Wnt/β-catenin signaling
Dihydroartemisinin inhibits endothelial cell proliferation through the suppression of the ERK signaling pathway
Dihydroartemisinin and gefitinib synergistically inhibit NSCLC cell growth and promote apoptosis via the Akt/mTOR/STAT3 pathway
Dihydroartemisinin inhibits liver cancer cell migration and invasion by reducing ATP synthase production through CaMKK2/NCLX